Key points are not available for this paper at this time.
overexpression drives SCLC chemoresistance and provide a therapeutic strategy to restore chemosensitivity.
Grunblatt et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: